94 followers
RT @FrontOncology: New research: AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study: Background Aldo-keto reduc…
RT @FrontOncology: New research: AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study: Background Aldo-keto reduc…
New research: AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study: Background Aldo-keto reductase 1B10 (AKR1B10) is a secretory protein that is upregulated in breast cancer.Objective This case-controlled pilot study… https://t.c